Hyperbaric oxygen therapy is well tolerated and effective for ulcerative colitis patients hospitaliz...
Hyperbaric oxygen therapy is well tolerated and effective for ulcerative colitis patients hospitalized for moderate-severe flares: a phase 2A pilot multi-center, randomized, double-blind, sham-controlled trial
About this item
Full title
Author / Creator
Dulai, Parambir S , Buckey, Jr, Jay C , Raffals, Laura E , Swoger, Jason M , Claus, Paul L , OʼToole, Kevin , Ptak, Judy A , Gleeson, Michael W , Widjaja, Christella E , Chang, John T , Adler, Jeffery M , Patel, Nihal , Skinner, Laurie A , Haren, Shawn P , Goldby-Reffner, Kimberly , Thompson, Kimberly D and Siegel, Corey A
Publisher
United States: Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins
Journal title
Language
English
Formats
Publication information
Publisher
United States: Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins
Subjects
More information
Scope and Contents
Contents
Hyperbaric oxygen therapy (HBOT) markedly increases tissue oxygen delivery. Case series suggest it may have a potential therapeutic benefit in ulcerative colitis (UC). We investigated the therapeutic potential of HBOT as an adjunct to steroids for UC flares requiring hospitalization.
The study was terminated early due to poor recruitment with 18...
Alternative Titles
Full title
Hyperbaric oxygen therapy is well tolerated and effective for ulcerative colitis patients hospitalized for moderate-severe flares: a phase 2A pilot multi-center, randomized, double-blind, sham-controlled trial
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2124761078
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2124761078
Other Identifiers
ISSN
0002-9270
E-ISSN
1572-0241
DOI
10.1038/s41395-018-0005-z
